483
Jubilant Generics LimitedFDA 483 - Jubilant Generics Limited - August 01, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Jubilant Generics Limited in Roorkee, India, revealed significant deficiencies in equipment design, cleaning, data integrity, and process control. The firm failed to demonstrate that production equipment was suitable for its intended use and free from contamination, and lacked appropriate controls over computerized systems. Additionally, hold time studies were found to be deficient, using unrepresentative product quantities.
Open in Dashboard
ID · 2fd780f0-354a-4b31-8a0a-a114b0a66789